International Journal of Drug Policy, Volume 85, November 2020 T. Platteau, C. Herrijgers, J. de Wit Abstract Chemsex among gay, bisexual and other men who have sex with men (GBMSM) has received increasing attention as a public health concern in recent years. Chemsex can affect a variety of aspects of the lives of GBMSM and contribute to physical, social and emotional health burden. Starting from...
Australian Institute of Health and Welfare, last updated 12/06/2020 Key Findings: People identifying as lesbian, gay or bisexual have relatively high rates of substance use. However, there is a lack of comprehensive data available on the associated harms for this population group. Almost one in 5 (18.7%) people identifying as homosexual or bisexual reported daily tobacco smoking in 2016, comapred...
Australian Institute of Health and Welfare, Last updated: 06 Aug 2020 Burden of disease is a measure of the years of healthy life lost from living with, or dying from disease and injury. A portion of this burden is preventable, being due to modifiable risk factors. This report provides information on the deaths and burden of disease due to risk factors included in the Australian Burden of...
Alcohol and Drug Foundation (Australia), April 27th 2020 There are now new challenges for people who access opioid replacement therapy (ORT) due to the COVID-19 (coronavirus) pandemic. Many may be experiencing anxiety and fear due to COVID-19 and trying to reduce and mitigate these feelings is vital. In most cases, people who are on ORT are required to visit their health clinic or pharmacy on a...
Centre for Social Research in Health, UNSW, July 2020 Priority groups at risk of blood borne viruses and sexually transmissible infections are still likely to experience negative behaviour from the general public and in healthcare settings according to a recent report from the Stigma Indicators Monitoring Project. 86% of the general public sampled self-reported that they would behave negatively...
Médecins du Monde Harm Reduction, April 2020 The COVID-19 pandemic is having a profound effect on the provision of health services across the globe and is further magnifying the existing barriers faced by people who use drugs in accessing harm reduction services. Programmes have had to adapt, and efforts are being made to enhance accessibility and ensure the continuity of harm reduction services...